Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Ther Deliv. 2013 Aug;4(8):10.4155/tde.13.72. doi: 10.4155/tde.13.72

Table 1.

Classification of exogenous surfactant preparations for pulmonary diseases.

Surfactant source Material Proteins Chemical name Trade name

Human surfactant
Human Amniotic fluid extract SP-A, SP-B, SP-C Not readily available
Natural surfactant
Animal bovine Modified minced lung extracts SP-B, SP-C Surfactant TA Beractant Surfacten®
Survanta®

Animal bovine Calf lung lavage extracts SP-B, SP-C CLSE
Calfactant
BLES®
Infasurf®

Animal bovine Cow lung lavage extracts SP-B, SP-C Bovactant Alveofact®

Animal porcine Minced lung extracts SP-B, SP-C Poractant alfa Curosurf®
Synthetic surfactant (lipid-based)

N/A DPPC None Nebulized DPPC N/A

N/A DPPC-PG None Pumactant ALEC®§

N/A CPHT None Colfosceril Exosurf®

N/A DPPC, HDL None Turfsurf N/A

N/A Apoproteins and synthetic
DPPC-DPPG
None Aposurf N/A
Synthetic surfactant (Lipid- and protein-based)
N/A N/A KL4 (sinapultide) Lucinactant Surfaxin®

N/A N/A 34-residue polypeptide based on SP-B Mini-B N/A

N/A N/A Dimeric SP-B1-25 Dimeric SP-B polypeptide N/A

N/A N/A rSP-C Recombinant SP-C (lusulptide) Venticute®

N/A N/A Poly-Leu SP-C analog SP-C33 N/A

N/A N/A N/A SP-A analogs N/A

N/A N/A N/A Truncated recombinant fragment of SP-D N/A

Minced lungs modified by the addition of phospholipids and fatty acids.

DPPC-PG at a weight ratio of 7:3.

§

Artificial lung-expanding compound.

Reconstituted from isolated low MW (≤15 K) apoproteins and synthetic dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol.

CLSE: Calf lung surfactant extract; CPHT: Colfosceril palmitate (dipalmitoylphosphatidylcholine), hexadecanol (cetyl alcohol) and tyloxapol; DPPC: Dipalmitoylphosphatidylcholine; KL4: Cationic and hydrophobic 21-residue lysine and leucine peptide; PG: Phosphatidylglcerol.